高尿酸血癥大鼠模型初探
[Abstract]:Hyperuricemia is a group of heterogeneous diseases caused by purine metabolic disorder and / or reduction of uric acid excretion. Hyperuricemia is characterized by elevated serum uric acid, which can be divided into primary and secondary ones, among which primary hyperuricemia accounts for the majority. In recent years, the incidence of hyperuricemia is increasing year by year, but its etiology and pathogenesis are still unclear. Suitable animal models are the basis for the study of these diseases, but due to the presence of uric acid enzymes in mice, the purine catabolism pathway is different from that of human beings due to the presence of uric acid enzymes in mice due to common laboratory animals such as large animals. It has brought great difficulties for the establishment of animal model of hyperuricemia. The commonly used modeling methods include direct supplementation of uric acid precursor or exogenous uric acid, elimination or inhibition of the activity of uric acid enzyme, inhibition of renal excretion of uric acid, etc. These methods have their own characteristics, but their duration is short. Kidney injury appeared early and severe, and there was still a certain gap between the occurrence and development of human primary hyperuricemia, so how to establish a stable and persistent animal model of hyperuricemia consistent with human abnormal uric acid metabolism. It is still worthy of continuous theoretical research and experimental exploration. In this study, fructose combined with potassium oxazinate was used in order to establish a stable, lasting hyperuricemia model with little liver and kidney damage in rats, and to provide a suitable animal model for the study of such diseases and the screening of therapeutic drugs. To investigate whether 5% fructose OAPS can be used to establish rat model of hyperuricemia. Fifteen male SD rats were randomly divided into two groups: blank group (n = 5), 10% fructose OAPS group (n = 5) and 5% fructose OAPS group (n = 5). The blank group was given standard diet 10% fructose OAPS group and 10% fructose water, and the OAPS milk suspension 100mg/ (kg.d) 5% fructose OAPS group was given standard feed and 5% fructose water twice a day. OAOS milk suspension 100mg/ (kg.d) was injected subcutaneously twice a day. The rats in each group were fed and drank freely for 13 weeks. The serum UA,BUN,Cr level was measured at different time points by severed blood. At the end of the experiment, the liver and kidney of the rats were taken for pathological sections. The results showed that 5% fructose OAPS could be used to establish animal model of hyperuricemia. To study the persistence, stability and liver and kidney injury of hyperuricemia animal model with 5% fructose OAPS. 40 male SD rats, They were randomly divided into 5% fructose OAPS group and 5% fructose OAPS group. The blank group was given 5% fructose water and 5% fructose water was subcutaneously injected with 5% fructose water sooner or later. The 5% fructose water group was subcutaneously injected subcutaneously with 5% fructose water in 5% fructose water. OAPS milk suspension was injected with 100 mg/ (kg.d), and the rats in each group were fed and drank freely. After 18 weeks, the serum UA,BUN,Cr level was measured at different time points, and the liver and kidney were taken for pathological sections at the end of the experiment. At the first week, the serum UA of 5% fructose OAPS group was significantly higher than that of the other groups (all P 0.01), and the serum UA of the 5% fructose group was higher than that of the blank group only at the 2nd week (P0.01). There was no difference in serum BUN,Cr level between the experimental group and the blank group. Statistical significance (P0.05), liver, No obvious injury was observed in renal tissue sections. This indicated that 5% fructose water combined with OAPS could establish a stable and lasting hyperuricemia animal model with little liver and kidney injury.
【學(xué)位授予單位】:重慶醫(yī)科大學(xué)
【學(xué)位級別】:碩士
【學(xué)位授予年份】:2017
【分類號】:R589.7;R-332
【參考文獻(xiàn)】
相關(guān)期刊論文 前10條
1 何宏明;馮育林;張武崗;李艷;左潔羽;楊世林;簡暉;李俊;;不同方法建立高尿酸血癥動物模型研究進(jìn)展[J];江西中醫(yī)藥;2015年12期
2 施琬;黃惠珠;李鐘;胡旭光;韓彬;;建立高尿酸血癥動物模型實驗研究[J];新中醫(yī);2015年06期
3 王紅坡;張冰;林志健;孫博喻;牛紅娟;朱春勝;王雪潔;;菊苣提取物對高甘油三酯并高尿酸血癥模型大鼠腸道菌群的影響[J];中醫(yī)藥信息;2015年03期
4 馬思佳;霍嬌;張立實;;高尿酸血癥動物模型研究進(jìn)展[J];衛(wèi)生研究;2015年01期
5 李麗玉;林志健;張冰;吳君德;王紅坡;王雪潔;牛紅娟;朱春勝;;連續(xù)高果糖飲水對大鼠尿酸水平的影響及其病理機(jī)制[J];中華臨床營養(yǎng)雜志;2014年06期
6 閆曼;安雅婷;李艦;吳智珍;王濤;;高尿酸血癥動物模型研究進(jìn)展[J];遼寧中醫(yī)藥大學(xué)學(xué)報;2014年09期
7 章友康;鄭法雷;;果糖與高尿酸血癥、代謝綜合征及腎臟疾病的關(guān)系[J];中華腎臟病雜志;2011年06期
8 任路平;宋光耀;;高果糖飲食與代謝綜合征研究新進(jìn)展[J];中國全科醫(yī)學(xué);2011年11期
9 劉淑芬;曾學(xué)軍;;高尿酸血癥動物模型研究進(jìn)展[J];基礎(chǔ)醫(yī)學(xué)與臨床;2011年03期
10 張美琳;黃國偉;;膳食因素與高尿酸血癥及代謝綜合征關(guān)系研究進(jìn)展[J];中國慢性病預(yù)防與控制;2010年04期
相關(guān)會議論文 前1條
1 潘洪志;;中國常見食物嘌呤數(shù)據(jù)庫的建立及膳食因素對血尿酸的影響[A];達(dá)能營養(yǎng)中心第十五屆學(xué)術(shù)研討會論文集[C];2012年
,本文編號:2249993
本文鏈接:http://sikaile.net/yixuelunwen/jichuyixue/2249993.html